{
    "@context": "https://api.researchmap.jp/researcher.jsonld",
    "@id": "https://api.researchmap.jp/read0007889?format=json",
    "@type": "researchers",
    "rm:user_id": "1000014162",
    "rm:creator_id": "1000014162",
    "rm:creator_type": "myself",
    "rm:created": "2010-10-17T15:00:00Z",
    "rm:modifier_id": "1000014162",
    "rm:modifier_type": "myself",
    "rm:modified": "2020-08-27T12:19:29Z",
    "permalink": "read0007889",
    "family_name": {
        "ja": "北川",
        "ja-Kana": "キタガワ",
        "en": "Kitagawa"
    },
    "given_name": {
        "ja": "昌伸",
        "ja-Kana": "マサノブ",
        "en": "Masanobu"
    },
    "display_name_kana": "disclosed",
    "display_nickname": "disclosed",
    "display_image": "disclosed",
    "display_contact_point": "disclosed",
    "affiliations": [
        {
            "display_job": "disclosed",
            "affiliation": {
                "ja": "東京医科歯科大学",
                "en": "Tokyo Medical and Dental University"
            },
            "section": {
                "ja": "大学院医歯学総合研究科 老化制御学系専攻加齢制御医学講座 包括病理学分野",
                "en": "Graduate School of Medical and Dental Sciences, Gerontology and Gerodontology Aging Control Medicine"
            },
            "job": {
                "ja": "教授",
                "en": "Professor"
            },
            "display_affiliation": "disclosed",
            "rm:institution_code": "0550000000"
        }
    ],
    "degrees": [
        {
            "degree": {
                "ja": "医学博士",
                "en": "(BLANK)"
            },
            "display_degree": "disclosed",
            "rm:institution_code": "9999999999"
        }
    ],
    "display_profile": "disclosed",
    "display_url": "disclosed",
    "identifiers": {
        "j_global_id": [
            "200901002952420330"
        ]
    },
    "rm:erad_id_verified": false,
    "rm:orc_id_verified": false,
    "display_erad_id": "closed",
    "display_orc_id": "closed",
    "display_researcher_id": "disclosed",
    "display_j_global_id": "disclosed",
    "see_also": [
        {
            "label": "j_global",
            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200901002952420330"
        }
    ],
    "@graph": [
        {
            "@id": "https://api.researchmap.jp/read0007889/research_interests",
            "@type": "research_interests",
            "@reverse": "https://api.researchmap.jp/read0007889",
            "total_items": 6,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_interests/1126145",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_interests",
                    "rm:id": "1126145",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "keyword": {
                        "ja": "人体病理学"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_interests/1126144",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_interests",
                    "rm:id": "1126144",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "keyword": {
                        "ja": "ウイルス学"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_interests/1126143",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_interests",
                    "rm:id": "1126143",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "keyword": {
                        "ja": "実験病理学"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_interests/1126142",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_interests",
                    "rm:id": "1126142",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "keyword": {
                        "en": "Human Pathology"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_interests/1126141",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_interests",
                    "rm:id": "1126141",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "keyword": {
                        "en": "Virology"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_interests/1126140",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_interests",
                    "rm:id": "1126140",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "keyword": {
                        "en": "Experimental Pathology"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0007889/research_areas",
            "@type": "research_areas",
            "@reverse": "https://api.researchmap.jp/read0007889",
            "total_items": 3,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_areas/590434",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_areas",
                    "rm:id": "590434",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A49060",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "ウイルス学",
                        "en": "Virology"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_areas/590433",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_areas",
                    "rm:id": "590433",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A49030",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "実験病理学",
                        "en": "Experimental pathology"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_areas/590432",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_areas",
                    "rm:id": "590432",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A49020",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "人体病理学",
                        "en": "Human pathology"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0007889/misc",
            "@type": "misc",
            "@reverse": "https://api.researchmap.jp/read0007889",
            "total_items": 30,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866697",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866697",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-31T06:34:47Z",
                    "paper_title": {
                        "en": "A novel role for acinus and MCM2 as host-specific signaling enhancers of DNA-damage-induced apoptosis in association with viral protein gp70"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Maki Hasegawa"
                            },
                            {
                                "name": "Morito Kurata"
                            },
                            {
                                "name": "Kouhei Yamamoto"
                            },
                            {
                                "name": "Kazuko Yoshida"
                            },
                            {
                                "name": "Shirou Aizawa"
                            },
                            {
                                "name": "Masanobu Kitagawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "The interaction of viral proteins with host-cellular proteins elicits the activation of numerous cellular signal transduction pathways possibly leading to the viral pathogenesis. We previously demonstrated that infection with Friend leukemia virus (FLV) radiosensitizes murine hematopoietic cells via a p53-dependent apoptotic pathway in C3H hosts. Here, we show that the transduction of the env-gene (gp70) of Friend murine leukemia virus (F-MuLV) sensitized C3H-derived myeloid leukemia cells to DNA-damage (ionizing radiation as well as doxorubicin)-induced apoptosis through the activation of DNA-dependent protein kinase (DNA-PK) and P53. Knockdown of DNA-PK by siRNA inhibited the radiosensitization induced by gp70. In association with gp70 and DNA-PK, the acinus and MCM2 proteins were host-specifically overexpressed in GH-derived cells. Taken together, these data suggested that gp70 enhances cellular DNA-damage-induced signaling in association with host-specific cellular proteins including acinus and MCM2 resulting in the activation of DNA-PK to phosphorylate P53. This in vitro study clearly indicates that the enhancement of DNA-damage-induced apoptosis by gp70 is not caused by the bone marrow environment of the host but is introduced by modified signaling in hematopoietic cells. The mechanisms involved in the ability of a viral protein to regulate cellular gene expression could provide invaluable insight into the manipulation of cellular pro-apoptotic signaling and the development of novel therapeutic strategies. (C) 2008 Elsevier Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "PERGAMON-ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2009-08",
                    "publication_name": {
                        "en": "LEUKEMIA RESEARCH"
                    },
                    "volume": "33",
                    "number": "8",
                    "starting_page": "1100",
                    "ending_page": "1107",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.leukres.2008.10.025"
                        ],
                        "issn": [
                            "0145-2126"
                        ],
                        "wos_id": [
                            "WOS:000266759000018"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.leukres.2008.10.025",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000266759000018&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866698",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866698",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-29T17:47:35Z",
                    "paper_title": {
                        "en": "Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Klio Konstantinou"
                            },
                            {
                                "name": "Kouhei Yamamoto"
                            },
                            {
                                "name": "Fumiaki Ishibashi"
                            },
                            {
                                "name": "Yuiko Mizoguchi"
                            },
                            {
                                "name": "Morito Kurata"
                            },
                            {
                                "name": "Yasunori Nakagawa"
                            },
                            {
                                "name": "Kenshi Suzuki"
                            },
                            {
                                "name": "Motoji Sawabe"
                            },
                            {
                                "name": "Masatsugu Ohta"
                            },
                            {
                                "name": "Shigesaburo Miyakoshi"
                            },
                            {
                                "name": "James T. Crawley"
                            },
                            {
                                "name": "Masanobu Kitagawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Angioimmunoblastic T-cell lymphoma (AILT) is a malignant disease of peripheral T-cell origin that is characterized by a prominent proliferation of high endothelial venules in the lymph node. To investigate angiogenic mechanisms in AILT we measured the angiogenic mediator gene expression levels in the lymph nodes of 54 non-Hodgkin lymphoma patients, by immunostaining and quantitative reverse transcription polymerase chain reaction. Angiogenic mediators angiopoietin (Ang) 1 (ANGPT1), Ang2 (ANGPT2) and their receptor, Tie2 (TEK), vascular endothelial growth factor (VEGF; VEGFA) and its receptor, VEGFR2 (KDR), and hepatocyte growth factor (HGF) and its receptor, c-Met (MET) were all more highly expressed in AILT lymph nodes (16 cases) than in B-cell lymphomas (24 cases). Moreover, significantly higher Ang1 and Tie2 expression was detected in AILT cases with CD10-positive neoplastic T-cells by comparison with unspecified peripheral T-cell lymphoma (14 cases). Immunostaining confirmed the expression of Ang1 and VEGF by both neoplastic T-cells and follicular dendritic cells. These results suggest that the angiopoietin system may play an important role in the development of high vascularity in AILT lymph nodes. Consequently, as neoplastic T-cells and follicular dendritic cells are both increased in AILT and may represent an important source of angiogenic mediators, targeting these cells with anti-angiogenic strategies might represent a novel therapy for AILT."
                    },
                    "publisher": {
                        "en": "WILEY-BLACKWELL PUBLISHING, INC"
                    },
                    "publication_date": "2009-03",
                    "publication_name": {
                        "en": "BRITISH JOURNAL OF HAEMATOLOGY"
                    },
                    "volume": "144",
                    "number": "5",
                    "starting_page": "696",
                    "ending_page": "704",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1111/j.1365-2141.2008.07534.x"
                        ],
                        "issn": [
                            "0007-1048"
                        ],
                        "wos_id": [
                            "WOS:000262826400008"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1111/j.1365-2141.2008.07534.x",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000262826400008&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866699",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866699",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-12T03:41:48Z",
                    "paper_title": {
                        "en": "Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Tamara Keith"
                            },
                            {
                                "name": "Yuko Araki"
                            },
                            {
                                "name": "Masaki Ohyagi"
                            },
                            {
                                "name": "Maki Hasegawa"
                            },
                            {
                                "name": "Kouhei Yamamoto"
                            },
                            {
                                "name": "Morito Kurata"
                            },
                            {
                                "name": "Yasunori Nakagawa"
                            },
                            {
                                "name": "Kenshi Suzuki"
                            },
                            {
                                "name": "Masanobu Kitagawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "To investigate the regulatory mechanisms of angiogenesis in the development of myelodysplastic syndromes (MDS) and its progression to overt leukaemia (OL), bone marrow samples from control, paired samples from MDS patients before and after transformation to OL (MDS -&gt; OL) and de novo acute myeloid leukaemia (AML) were analysed. Immunohistochemical staining showed a significant increase of bone marrow microvascular density (MVD) in MDS and de novo AML compared with controls. Surprisingly, in MDS, MVD significantly decreased upon transformation to OL, which was also significantly lower than the MVD of de novo AML. This evidence was strengthened by the pattern of angiogenic mediator gene expression, confirming the importance of various angiogenic mediators including vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), tumour necrosis factor alpha (TNF alpha), hepatocyte growth factor (HGF) and the angiopoietin family of mediators (Ang-1 and Ang-2) as well as the receptors for angiogenic mediators, such as VEGF receptor 2 (VEGFR2) and the tyrosine kinase receptor, TIE2. By contrast, the anti-angiogenic mediator, transforming growth factor-beta (TGF beta) exhibited significantly higher expression in the bone marrow of MDS -&gt; OL, indicating the importance of this cytokine as the suppressive factor of angiogenesis in MDS. These findings indicate that the bone marrow microenvironment in MDS -&gt; OL and de novo AML differs remarkably, suggesting the different efficacy of anti-angiogenic therapy between de novo AML and leukaemia secondary to MDS."
                    },
                    "publisher": {
                        "en": "BLACKWELL PUBLISHING"
                    },
                    "publication_date": "2007-05",
                    "publication_name": {
                        "en": "BRITISH JOURNAL OF HAEMATOLOGY"
                    },
                    "volume": "137",
                    "number": "3",
                    "starting_page": "206",
                    "ending_page": "215",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1111/j.1365-2141.2007.06539.x"
                        ],
                        "issn": [
                            "0007-1048"
                        ],
                        "wos_id": [
                            "WOS:000245393400003"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1111/j.1365-2141.2007.06539.x",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000245393400003&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866696",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866696",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-06-06T04:07:54Z",
                    "paper_title": {
                        "en": "Role of lymphoid cells in age-related change of susceptibility to Friend leukemia virus-induced leukemia"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "S Yamaguchi"
                            },
                            {
                                "name": "M Kitagawa"
                            },
                            {
                                "name": "M Inoue"
                            },
                            {
                                "name": "Y Tejima"
                            },
                            {
                                "name": "M Kimura"
                            },
                            {
                                "name": "S Aizawa"
                            },
                            {
                                "name": "M Utsuyama"
                            },
                            {
                                "name": "K Hirokawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Susceptibility for Friend leukemia virus (FLV)-induced leukemogenesis was examined in the C3H/He (C3H) --&gt; C57BL/6 (B6) radiation bone marrow chimeras of various age groups. and the effect of aging of host mice on the susceptibility was determined. The hone marrow chimera system provided the various age of FLV-resistant host mice (B6) possessing the same age of FLV-susceptible target cells from C3H mice. Using this system. we could determine the aging effect on the host resistancy against FLV without an influence of the aging effect on target cells. First. the young C3H --&gt; young B6 chimeras and young C3H --&gt; old B6 chimeras were compared. The young --&gt; old chimeras were more susceptible to FLV-induced acute disease than the young --&gt; young chimeras. The spleen CD4(+) as well as CD8(+) T cells were reduced in young-told chimeras compared with young --&gt; young chimeras. Similarly, the old C3H --&gt; old B6 chimeras were more susceptible than old --&gt; young chimeras and revealed the lower CD4(+) T cell ratio in the spleen. Discussion was made on the possible implication of these findings on the role of T cells in age-related change of resistance to FLV-induced leukemogenesis. (C) 2001 Elsevier Science ireland Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCI IRELAND LTD"
                    },
                    "publication_date": "2001-02",
                    "publication_name": {
                        "en": "MECHANISMS OF AGEING AND DEVELOPMENT"
                    },
                    "volume": "122",
                    "number": "2",
                    "starting_page": "219",
                    "ending_page": "232",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0047-6374(00)00245-1"
                        ],
                        "issn": [
                            "0047-6374"
                        ],
                        "wos_id": [
                            "WOS:000167031500014"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0047-6374(00)00245-1",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000167031500014&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866695",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866695",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-15T07:58:15Z",
                    "paper_title": {
                        "en": "Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "S Yamaguchi"
                            },
                            {
                                "name": "M Kitagawa"
                            },
                            {
                                "name": "M Inoue"
                            },
                            {
                                "name": "N Tomizawa"
                            },
                            {
                                "name": "R Kamiyama"
                            },
                            {
                                "name": "K Hirokawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Angioimmunoblastic lymphadenopathy (AILD)-type T cell lymphoma is histologically characterized by a mixed infiltrate of atypical T cells and B cells including B immunoblasts and plasma cells as well as eosinophils accompanied by proliferation of high endothelial venules. These morphological peculiarities are widely believed to reflect an abnormal pattern of cytokine expression. To clarify the cell dynamics and cytokine expression pattern in the lymph nodes of AILD-type T cell lymphoma, the frequency of proliferating/apoptotic cells and localization of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 producing cells were determined. Double staining was performed for (1) cell markers and Ki-67 antigen, (2) cell markers and the terminal deoxytransferase-mediated dUTP nick end labeling (TUNEL) method, or (3) cell markers and cytokines. The proliferating cell ratio in atypical T cells of AILD-type T cell lymphoma determined by Ki-67 labeling was 20.2 +/- 5.0%, while other peripheral T cell lymphomas (PTL) exhibited a ratio of 32.9 +/- 2.5%. TUNEL-positive apoptotic cells were 0.8 +/- 0.1% of total cells in AILD-type T cell lymphoma. They were dominantly atypical cells with positive T cell markers. In contrast, lymphoma cells in other types of PTL or paracortical cells in reactive follicular hyperplasia had only 0.3 +/- 0.1 or 0.4 +/- 0.1% TUNEL-positive cells, respectively. Thus, lymphoma cells in AILD-type T cell lymphoma demonstrated suppressed proliferating activity and enhanced apoptosis when compared to other types of PTL. TNF-alpha-producing cells were observed in all of the lymph nodes from AILD-type T cell lymphoma cases (15/15) and positive staining was obtained in the majority of atypical T cells and scattered macrophages. In contrast, IL-6 was localized to clusters of atypical T cells in some of the cases (9/15). Further, the expression of TNF-alpha, IL-6, and TNF receptors I and II (TNFRI and TNFRII) was examined by RT-PCR. The TNF-alpha message (2/2) and IL-6 message (2/2) was present in the lymph nodes of AILD-type T cell lymphoma by examination using RT-PCR, while both messages were negative in control cases (0/7). As far as an expression of mRNA for TNF receptors in AILD-type T cell lymphoma cases, mRNA for TNFRI was definitely expressed in both of the cases (2/2) while TNFRII mRNA was weakly expressed in one case (1/2). Overexpression of TNF-alpha as well as TNFRI may play a role in controlling T cell proliferation through an autocrine (T cell-T cell interaction) and paracrine (macrophage-T cell interaction) fashion. IL-6, which was also expressed by part of lymphoma cells of AILD-type T cell lymphoma, facilitates the proliferation of B cells, plasma cells, and T cells or endothelial cells in the lymph nodes of AILD-type T cell lymphoma. (C) 2000 Academic Press."
                    },
                    "publisher": {
                        "en": "ACADEMIC PRESS INC"
                    },
                    "publication_date": "2000-04",
                    "publication_name": {
                        "en": "EXPERIMENTAL AND MOLECULAR PATHOLOGY"
                    },
                    "volume": "68",
                    "number": "2",
                    "starting_page": "85",
                    "ending_page": "94",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1006/exmp.1999.2297"
                        ],
                        "issn": [
                            "0014-4800"
                        ],
                        "wos_id": [
                            "WOS:000086030800002"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1006/exmp.1999.2297",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000086030800002&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866694",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866694",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-07T06:08:36Z",
                    "paper_title": {
                        "en": "Expression of inducible nitric oxide synthase (NOS) in bone marrow cells of myelodysplastic syndromes"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Kitagawa"
                            },
                            {
                                "name": "M Takahashi"
                            },
                            {
                                "name": "S Yamaguchi"
                            },
                            {
                                "name": "M Inoue"
                            },
                            {
                                "name": "S Ogawa"
                            },
                            {
                                "name": "K Hirokawa"
                            },
                            {
                                "name": "R Kamiyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Nitric oxide (NO) is a biological mediator which is synthesized from L-arginine by a family of nitric oxide synthases (NOS). We have studied the expression of the inducible NOS (iNOS) by bone marrow cells from the patients with myelodysplastic syndromes (MDS) at the mRNA level by RT-PCR assay and at the protein level by immunohistochemical staining using a specific anti-iNOS monoclonal antibody. The iNOS message was present in 92% of bone marrow tissues from MDS patients (11 out of 12) by an examination using RT-PCR. Basically, iNOS message was negative or very weak in control (1/9) and AML (0/7) cases. This was supported by immunohistochemical findings that the iNOS was positive in most of the bone marrow samples from MDS patients (9 out of 12), while bone marrow cells of control (0 out of 12) and AML (0 out of 5) cases were basically negative. Double immunostaining for CD68 antigen, which is a marker for macrophage lineage cells, and iNOS was performed on MDS bone marrow sections. iNOS was dominantly localized to bone marrow macrophages, although a part of myeloid cells were also positively stained with anti-iNOS antibody in a part of cases. These results indicated that there is some in vivo induction of iNOS expression for local NO production that might be involved in the dysregulation of hematopoiesis in bone marrow of MDS."
                    },
                    "publisher": {
                        "en": "STOCKTON PRESS"
                    },
                    "publication_date": "1999-05",
                    "publication_name": {
                        "en": "LEUKEMIA"
                    },
                    "volume": "13",
                    "number": "5",
                    "starting_page": "699",
                    "ending_page": "703",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0887-6924"
                        ],
                        "wos_id": [
                            "WOS:000080253800006"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000080253800006&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866693",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866693",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-05T13:25:26Z",
                    "paper_title": {
                        "en": "Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Kitagawa"
                            },
                            {
                                "name": "S Aizawa"
                            },
                            {
                                "name": "H Kamisaku"
                            },
                            {
                                "name": "K Hirokawa"
                            },
                            {
                                "name": "H Ikeda"
                            }
                        ]
                    },
                    "description": {
                        "en": "Fv-4 is a mouse gene that dominantly confers resistance to infection by ecotropic murine leukemia virus (MuLV), We have demonstrated previously that bone marrow chimeras in which hematopoietic cells were replaced with cells expressing Fv-4 resistant (Fv-4(r)) gene product became refractory to Friend leukemia virus (FLV)-induced leukemogenesis. To induce in vivo resistance against retrovirus-induced diseases by retroviral vector-mediated gene transduction, me introduced Fv-4(r) env gene into bone marrow cells of FLV-susceptible C3H/He (C3H) mice with retroviral vector (pLSF) derived from murine Friend spleen focus forming virus (SFFV) and the cells were transplanted into lethally irradiated C3H mice. After the bone marrow transplantation, Fv-4(r) gene product was successfully expressed on erythroid and myeloid cells, while lymphoid cells were only weakly expressing Fv-4(r) gene product, The C3H mice expressing relatively higher amounts of Fv-4(r) gene product were rendered resistant to FLV-induced erythroleukemia, while mice expressing lower amounts of the Fv-4 gene product were still susceptible. Effective protection of FLV-induced leukemia in these mice suggested that the Fv-4(r) gene expression by erythroid cells that were the major target of FLV infection might be critical for resisting FLV-induced leukemia. Thus, gene therapy model by transducing Fv-4 env gene using bone marrow transplantation would provide a useful protection model system of retrovirus-induced diseases, (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc."
                    },
                    "publisher": {
                        "en": "ELSEVIER SCIENCE INC"
                    },
                    "publication_date": "1999-02",
                    "publication_name": {
                        "en": "EXPERIMENTAL HEMATOLOGY"
                    },
                    "volume": "27",
                    "number": "2",
                    "starting_page": "234",
                    "ending_page": "241",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0301-472X(98)00040-X"
                        ],
                        "issn": [
                            "0301-472X"
                        ],
                        "wos_id": [
                            "WOS:000078567300007"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0301-472X(98)00040-X",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000078567300007&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866692",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866692",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-24T13:41:49Z",
                    "paper_title": {
                        "en": "Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Kitagawa"
                            },
                            {
                                "name": "S Yamaguchi"
                            },
                            {
                                "name": "M Takahashi"
                            },
                            {
                                "name": "T Tanizawa"
                            },
                            {
                                "name": "K Hirokawa"
                            },
                            {
                                "name": "R Kamiyama"
                            }
                        ]
                    },
                    "description": {
                        "en": "Frequent apoptosis in the bone marrow of patients with myelodysplastic syndromes (MDS) was demonstrated on frozen sections using the terminal deoxytransferase (TdT)-mediated dUTP nick end labeling (TUNEL) method. The overall mean percentage of TUNEL-positive cells was about 17% in the bone marrow of MDS, while bone marrow from control cases exhibited a mean of 3.4% (P&lt;0.001). To elucidate the mechanism of apoptosis in bone marrow cells of MDS, the expression of Fas antigen and Fas ligand (FasL) was examined by RT-PCR and immunohistochemistry. All MDS cases showed expression of Fas mRNA (12/12) and most exhibited an expression of Fast mRNA (10/12) by RT-PCR. Basically, control cases did not show positive signals for Fas and Fast mRNA, however, a very weak band was detected in three cases (3/10) for Fas and in one case (1/10) for Fast mRNA by RT-PCR. Immunohistochemical examination revealed positive staining for Fas (11/12) and Fast (12/12) in the bone marrow of MDS, while all the bone marrow samples from control cases were negative for anti-fas (0/15) and for anti-Fast (0/15) antibody. Double staining clarified that TUNEL-positive apoptotic cells expressed Fas antigen on the cell surface, although not all Fas-positive cells were TUNEL positive. The Fas-positive cells of MDS bone marrow included hematopoietic cells expressing CD34 antigen, neutrophil elastase, a marker for myeloid series of cells, or glycophorin A, a marker for erythroid cells. However, CD68-positive cells which were macrophage lineage cells, did not express Fas antigen strongly. In contrast, positive staining for Fast was detected in hematopoietic cells and CD68-positive cells in the bone marrow of MDS, These results suggest that the Fas-FasL system plays an important role in inducing apoptosis in the bone marrow of MDS and works in an autocrine (hematopoietic cell-hematopoietic cell interaction) and/or paracrine (hematopoietic cell-stromal cell interaction) manner."
                    },
                    "publisher": {
                        "en": "STOCKTON PRESS"
                    },
                    "publication_date": "1998-04",
                    "publication_name": {
                        "en": "LEUKEMIA"
                    },
                    "volume": "12",
                    "number": "4",
                    "starting_page": "486",
                    "ending_page": "492",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1038/sj.leu.2400980"
                        ],
                        "issn": [
                            "0887-6924"
                        ],
                        "wos_id": [
                            "WOS:000073279900006"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1038/sj.leu.2400980",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000073279900006&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866691",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866691",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-15T08:43:20Z",
                    "paper_title": {
                        "en": "Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Kitagawa"
                            },
                            {
                                "name": "Saito, I"
                            },
                            {
                                "name": "T Kuwata"
                            },
                            {
                                "name": "S Yoshida"
                            },
                            {
                                "name": "S Yamaguchi"
                            },
                            {
                                "name": "M Takahashi"
                            },
                            {
                                "name": "T Tanizawa"
                            },
                            {
                                "name": "R Kamiyama"
                            },
                            {
                                "name": "K Hirokawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "To clarify whether regulatory cytokines inhibit hematopoiesis in patients with myelodysplastic syndromes (MDS), malignancies characterized by the formation of cytopenias despite the presence of cellular bone marrow, expression of TNF-alpha and IFN-gamma by bone marrow cells was investigated using specific reverse transcriptase-polymerase chain reaction assays. An enhanced expression of the mRNA for TNF-alpha was observed in most of the samples from MDS patients (11/14, 79%), whereas no enhancement was observed in bone marrow samples from AML (0/6), CML (0/2) or control cases (0/8). The expression of IFN-gamma was also enhanced in some of MDS cases (5/12, 42%) while AML (0/5), CML (0/2) and control cases (0/6) showed very low levels of IFN-gamma mRNA expression. Immunohistochemical examination confirmed the scattered presence of TNF-alpha or IFN-gamma producing cells in the bone marrow of MDS patients. The majority of these cells were CD68-positive macrophage lineage cells. These results suggested that disruption of hematopoiesis in MDS might be caused by enhanced production of inhibitory regulatory cytokines especially TNF-alpha and occasionally IFN-gamma by bone marrow macrophages."
                    },
                    "publisher": {
                        "en": "STOCKTON PRESS"
                    },
                    "publication_date": "1997-12",
                    "publication_name": {
                        "en": "LEUKEMIA"
                    },
                    "volume": "11",
                    "number": "12",
                    "starting_page": "2049",
                    "ending_page": "2054",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0887-6924"
                        ],
                        "wos_id": [
                            "WOS:000071544900007"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000071544900007&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866690",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866690",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-27T12:19:29Z",
                    "paper_title": {
                        "en": "Cell-free transmission of Fv-4 resistance gene product controlling Friend leukemia virus-induced leukemogenesis in mice"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Masanobu Kitagawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Fv-4 is a mouse gene that dominantly confers resistance to infection by ecotropic murine leukemia virus (MuLV). The Fv-4′ env antigen that binds to the cell surface of Fv-4′-bearing C3H cells was found in sera from normal Fv-4′ -bearing C4W mice. The serum Fv-4′ env antigen binds to ecotropic MuLV receptors, shown by specific binding to transfectant cells expressing ecotropic MuLV receptors but not to parental mink cells. To determine whether the binding of Fv-4′ env antigen to the putative MuLV receptors would block FLV infection, C3H thymocytes or spleen cells that had been preincubated with C4W serum were mixed with FLV and the subsequent production of MuLV specific antigens was examined. C3H thymocytes or spleen cells treated with C4W serum became refractory to binding by FLV. These results provide evidence that the Fv-4′ env antigen is released from C4W-derived cells in vivo and binds to cells expressing surface receptors for ecotropic MuLV, thereby protecting them from infection with FLV. The implication of these findings for gene therapy of retrovirus-induced disease such as acquired immune deficiency syndrome (AIDS) is discussed."
                    },
                    "publisher": {
                        "en": "Nature Publishing Group"
                    },
                    "publication_date": "1997",
                    "publication_name": {
                        "en": "Leukemia"
                    },
                    "volume": "11",
                    "number": "3",
                    "starting_page": "230",
                    "ending_page": "232",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0887-6924"
                        ],
                        "pm_id": [
                            "9209350"
                        ],
                        "scopus_id": [
                            "0030750399"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/9209350",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866688",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866688",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-09T20:14:52Z",
                    "paper_title": {
                        "en": "Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4(r) mouse strain"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Kitagawa"
                            },
                            {
                                "name": "S Aizawa"
                            },
                            {
                                "name": "H Kamisaku"
                            },
                            {
                                "name": "T Sado"
                            },
                            {
                                "name": "H Ikeda"
                            },
                            {
                                "name": "K Hirokawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Fv-4 is a mouse gene that dominantly confers resistance to infection by ecotropic murine leukemia virus (MuLV). We demonstrated previously that the Fv-4 resistant (Fv-4(r)) gene product, Fv-4(r) env antigen, is released from Fv-4(r)-bearing BALB/c-Fv-4M(r) (C4W) mouse-derived cells into serum in vivo and binds to cells expressing surface receptors for ecotropic MuLV, thereby protecting them from infection with Friend leukemia virus (FLV) by receptor interference. This unique resistance mechanism against retroviral infection might provide a possible therapeutic model system of human retroviral infection such as AIDS. To further investigate the Fv-4(r) gene action in vivo, we examined the distribution and character of Fv-4(r) env antigen in serum and systemic organs from C4W mice. The Fv-4(r) env antigen was immunohistochemically localized to the lympho-hematopoietic cells and exocrine glandular cells, such as those of the salivary gland and pancreas. Using immunoprecipitation followed by Western blotting, we determined two types of gp70-related Fv-4(r) env antigen in the serum of C4W mice, showing molecular weights of either 70-75 kDa and 80-85 kDa. When thymocytes from Fv-4 susceptible gene (Fv-4(s))-bearing C3H mouse were mixed with C4W mouse serum, the 70-75k Da molecule of the C4W serum dominantly bound to C3H thymocytes and thus contributed to receptor interference function. Using immunoelectron microscopy, Fv-4(r) env antigen was mainly localized to the cell surface membrane of thymic lymphoid cells, while acinar cells of the salivary gland possessed Fv-4(r) env antigen in the endoplasmic reticulum (ER) as well as on the cell surface membrane. These data indicate that several glandular organs, as well as lymphohematopoietic organs of C4W mice, may contribute to the production of cell-free Fv-4(r) env antigen, resulting in protection of cells from infection with FLV by receptor interference."
                    },
                    "publisher": {
                        "en": "CARDEN JENNINGS PUBL CO LTD"
                    },
                    "publication_date": "1996-10",
                    "publication_name": {
                        "en": "EXPERIMENTAL HEMATOLOGY"
                    },
                    "volume": "24",
                    "number": "12",
                    "starting_page": "1423",
                    "ending_page": "1431",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0301-472X"
                        ],
                        "wos_id": [
                            "WOS:A1996VR97300009"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:A1996VR97300009&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866689",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866689",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "paper_title": {
                        "en": "Establishment of a therapeutic model for retroviral infection by genetic resistance mechanism of the host."
                    },
                    "publication_date": "1996",
                    "publication_name": {
                        "en": "Pathology International"
                    },
                    "volume": "46",
                    "number": "10",
                    "starting_page": "719",
                    "ending_page": "725",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866687",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866687",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-10T17:31:07Z",
                    "paper_title": {
                        "en": "CELL-FREE TRANSMISSION OF FV-4 RESISTANCE GENE-PRODUCT CONTROLLING FRIEND-LEUKEMIA VIRUS-INDUCED LEUKEMOGENESIS - A UNIQUE MECHANISM FOR INTERFERENCE WITH VIRAL-INFECTION"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M KITAGAWA"
                            },
                            {
                                "name": "S AIZAWA"
                            },
                            {
                                "name": "H KAMISAKU"
                            },
                            {
                                "name": "H IKEDA"
                            },
                            {
                                "name": "K HIROKAWA"
                            },
                            {
                                "name": "T SADO"
                            }
                        ]
                    },
                    "description": {
                        "en": "Fv-4 is a mouse gene that dominantly confers resistance to infection by ecotropic murine leukemia virus (MuLV). We previously demonstrated that mixed radiation bone marrow chimeras containing Fv-4'-bearing BALB/c-Fv-4W' (C4W) bone marrow and Fv-4(s)-bearing C3H/He (C3H) bone marrow grafted into C3H recipient mice (C4W + C3H --&gt; C3H) were resistant to Friend leukemia virus (FLV)-induced leukemogenesis, even when they contained as high as 70% C3H-derived cells. This indicates that FLV-sensitive C3H-derived cells are rendered refractory to infection and/or transformation with FLV when they coexist in mice with Fv-4'-bearing cells. To investigate the mechanism of Fv-4 resistance to FLV-induced leukemogenesis, we first examined the expression of Fv-4' env antigen in the peripheral blood mononuclear cells (PBMC) of these chimeras. The Fv-4' env antigen was present not only on C4W-derived cells, but also on Fv-4(s)-bearing C3H-derived cells in C4W + C3H --&gt; C3H mixed bone marrow chimeras. The Fv-4' env antigen that binds to the cell surface of C3H cells was found in sera from normal C4W mice, C4W --&gt; C3H chimeras, and C4W + C3H --&gt; C3H mixed chimeras. The serum Fv-4' env antigen binds to ecotropic MuLV receptors, shown by specific binding to transfectant mink cells expressing ecotropic MuLV receptor, but not to parental mink cells. To determine whether the binding of Fv-4' env antigen to the putative MuLV receptors would block FLV infection, C3H thymocytes or spleen cells that had been preincubated with C4W serum were mixed with FLV and the subsequent production of MuLV specific antigens was examined. C3H thymocytes or spleen cells treated with C4W serum became refractory to binding by FLV. These results provide evidence that the Fv-4' env antigen is released from C4W-derived cells in vivo and binds to cells expressing surface receptors for ecotropic MuLV, thereby protecting them from infection with FLV. The implication of these findings for gene therapy of retrovirus-induced disease such as acquired immune deficiency syndrome (AIDS) is discussed. (C) 1995 by The American Society of Hematology."
                    },
                    "publisher": {
                        "en": "W B SAUNDERS CO"
                    },
                    "publication_date": "1995-08",
                    "publication_name": {
                        "en": "BLOOD"
                    },
                    "volume": "86",
                    "number": "4",
                    "starting_page": "1557",
                    "ending_page": "1563",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0006-4971"
                        ],
                        "wos_id": [
                            "WOS:A1995RN46700042"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:A1995RN46700042&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866686",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866686",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "paper_title": {
                        "en": "Epstein-Barr virus infection is not frequent in bone marrow from parients with myelodysplastic syndromes"
                    },
                    "publication_date": "1995",
                    "publication_name": {
                        "en": "European Journal of Haematology"
                    },
                    "number": "55",
                    "starting_page": "199",
                    "ending_page": "201",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866685",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866685",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-13T20:34:25Z",
                    "paper_title": {
                        "en": "BONE-MARROW TRANSPLANTATION FROM FV-4-RESISTANT DONORS RESCUES FRIEND-LEUKEMIA VIRUS-INFECTED MICE FROM LEUKEMIA - A MODEL OF BONE-MARROW TRANSPLANTATION THERAPY AGAINST RETROVIRAL INFECTION"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M KITAGAWA"
                            },
                            {
                                "name": "H KAMISAKU"
                            },
                            {
                                "name": "S AIZAWA"
                            },
                            {
                                "name": "T SADO"
                            }
                        ]
                    },
                    "description": {
                        "en": "Bone marrow transplantation experiments were conducted in mice in order to develop an experimental bone marrow transplantation therapy model, with which to investigate possible means to cure retrovirus-infected hosts with bone marrow or stem cells from virus-resistant donors. In one experiment, lethally irradiated Friend leukemia virus (FLV)-sensitive C3H/He (C3H; Fv-2(s), Fv-4(s), Rfv-1(s), Rfv-2(s) Rfv-3(s)) mice were transplanted with (i) bone marrow cells from FLV-resistant BALB/c-Fv-4W(r) (C4W; Fv-2(s), Fv-4(r), Rfv-1(s), Rfv-2(s), Rfv-3(s)) mice (C4W --&gt; C3H) or (ii) a mixture of bone marrow cells from C4W and C3H mice (C4W + C3H --&gt; C3H). They were then inoculated with FLV 3-4 months later and leukemia development was examined. The results indicated that C4W + C3H chimeras were completely resistant to FLV-induced leukemogenesis and that C4W + C3H --&gt; C3H mixed chimeras that contained as low as 30% C4W-derived cells, or as high as 70% C3H-derived cells, did not develop leukemias. In another experiment, bone marrow cells from C57BL/6 (B6; Fv-2(r), Fv-4(s), Rfv-1(r), Rfv-2(r), Rfv-3(r)) or C4W donors were grated to FLV-sensitive DBA/2 mice (DBA; Fv-2(s), Fv-4(s), Rfv-1(s), Rfv-2(s), Rfv-3(s)) that had been infected with FLV 6 days earlier (DBA-FLV). The results indicated that most, if not all, FLV-infected DBA mice which received bone marrow transplantation from B6 donors developed BG-derived leukemias, although the survival time of these mice was dramatically prolonged as compared to that of untreated DBA-FLV mice. In contrast, bone marrow transplantation from Fv-4(r)-bearing C4W donors successfully rescued FLV-infected DBA mice from leukemic deaths. Thus, the bone marrow transplantation therapy against retroviral infection of hemopoietic cells was shown to be feasible, provided that donor cells carry a resistant allele that functions via receptor blockade as in the case of Fv-4(r), but less effective when the roles of the resistant alleles partially interfered with the virus replication, leukemic transformation and/or cycling of target cells as suggested for Fv-2(r) gene action, or to resist virus infection by immunological means as are known for Rfv-1(r), Rfv-2(r) and Rfv-3(r) genes which are also carried by B6-strain mice. Implication of these findings on the somatic gene therapy against retrovirus infection diseases in man are discussed."
                    },
                    "publisher": {
                        "en": "STOCKTON PRESS"
                    },
                    "publication_date": "1994-12",
                    "publication_name": {
                        "en": "LEUKEMIA"
                    },
                    "volume": "8",
                    "number": "12",
                    "starting_page": "2200",
                    "ending_page": "2206",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0887-6924"
                        ],
                        "wos_id": [
                            "WOS:A1994QB45100026"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:A1994QB45100026&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866684",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866684",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "paper_title": {
                        "en": "p53 expression in myeloid cells of myelodysplastic ayndromes : Association with evolution of overt leuekmia"
                    },
                    "publication_date": "1994",
                    "publication_name": {
                        "en": "American Journal of Pathology"
                    },
                    "volume": "145",
                    "number": "2",
                    "starting_page": "338",
                    "ending_page": "344",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866683",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866683",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "paper_title": {
                        "en": "Immunolocalization of platelet-derived growth factor, transforming growth factor-β and fibronectin in acute megakaryoblastic leukemia manifesting tumor formation"
                    },
                    "publication_date": "1994",
                    "publication_name": {
                        "en": "Human Pathology"
                    },
                    "number": "25",
                    "starting_page": "723",
                    "ending_page": "726",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866680",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866680",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-18T05:47:22Z",
                    "paper_title": {
                        "en": "FRIEND-LEUKEMIA VIRUS-INDUCED LEUKEMOGENESIS IN FULLY H-2 INCOMPATIBLE C57BL/6-]C3H RADIATION BONE-MARROW CHIMERAS"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M KITAGAWA"
                            },
                            {
                                "name": "H KAMISAKU"
                            },
                            {
                                "name": "T SADO"
                            },
                            {
                                "name": "T KASUGA"
                            }
                        ]
                    },
                    "description": {
                        "en": "Resistance and/or susceptibility for Friend leukemia virus (FLV)-induced leukemogenesis was examined in the fully H-2 incompatible C57BL/6 (B6)--&gt; C3H radiation bone marrow chimeras (RBMC). The results indicated that B6--&gt;C3H chimeras never developed FLV-induced leukemias when infected with FLV 4 months after bone marrow transplantation (BMT). Spleen cells from B6--&gt;C3H chimeras that were preimmunized with 100 Gy-irradiated FBL-3 cells (FLV-induced leukemic cell line originated from B6 mice) were shown to generate anti-FBL-3 specific T-cell proliferation as well as cytotoxic T cells. We also found that when bone marrow cells from B6 mice were mixed with those from C3H mice and then grafted into supralethally irradiated C3H mice, resulting chimeras whose peripheral blood contained less than 30% C3H-derived (susceptible) cells were refractory to FLV-induced leukemogenesis. On the other hand, when C3H mice were infected with FLV and then supralethally irradiated 5 days later and grafted with bone marrow from B6 donors, they developed leukemias which were of B6 origin. Athymic nu/nu mice of B6 background were again shown to develop leukemia following infection with FLV. Possible implication of these findings on the role of T cell-mediated immune response in resistance to FLV-induced leukemogenesis and the immunocompetent nature of fully H-2 incompatible RBMC were discussed."
                    },
                    "publisher": {
                        "en": "STOCKTON PRESS"
                    },
                    "publication_date": "1993-07",
                    "publication_name": {
                        "en": "LEUKEMIA"
                    },
                    "volume": "7",
                    "number": "7",
                    "starting_page": "1041",
                    "ending_page": "1046",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0887-6924"
                        ],
                        "wos_id": [
                            "WOS:A1993LP12700017"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:A1993LP12700017&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866682",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866682",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "paper_title": {
                        "en": "In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma"
                    },
                    "publication_date": "1993",
                    "publication_name": {
                        "en": "Journal of Cancer Research and Clinical Oncology"
                    },
                    "volume": "119,470-474",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/misc/6866681",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0007889/misc",
                    "rm:id": "6866681",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "paper_title": {
                        "en": "Increase in number of bone marrow macrophages in patients with myelodysplastic syndromes"
                    },
                    "publication_date": "1993",
                    "publication_name": {
                        "en": "European Journal of Haematology"
                    },
                    "volume": "51,56-58",
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0007889/association_memberships",
            "@type": "association_memberships",
            "@reverse": "https://api.researchmap.jp/read0007889",
            "total_items": 3,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0007889/association_memberships/807768",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0007889/association_memberships",
                    "rm:id": "807768",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本免疫学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/association_memberships/807767",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0007889/association_memberships",
                    "rm:id": "807767",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本癌学会"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/association_memberships/807766",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0007889/association_memberships",
                    "rm:id": "807766",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "academic_society_name": {
                        "ja": "日本病理学会"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0007889/research_projects",
            "@type": "research_projects",
            "@reverse": "https://api.researchmap.jp/read0007889",
            "total_items": 4,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_projects/1046975",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_projects",
                    "rm:id": "1046975",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "research_project_title": {
                        "ja": "骨髄異形成症候群の病態解明に関する研究"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_projects/1046974",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_projects",
                    "rm:id": "1046974",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "research_project_title": {
                        "ja": "レトロウイルス感染に対する宿主抵抗性発現の機構に関する研究"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_projects/1046973",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_projects",
                    "rm:id": "1046973",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "research_project_title": {
                        "en": "Study on Pathogenesis of Myelodysplastic Syndromes"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                },
                {
                    "@id": "https://api.researchmap.jp/read0007889/research_projects/1046972",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0007889/research_projects",
                    "rm:id": "1046972",
                    "rm:user_id": "1000014162",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000014162",
                    "rm:creator_type": "myself",
                    "rm:created": "2010-10-17T15:00:00Z",
                    "rm:modifier_id": "1000014162",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2010-10-17T15:00:00Z",
                    "research_project_title": {
                        "en": "Study on Host Resistance against Retroviral Infection"
                    },
                    "overall_grant_amount": {
                        "indirect_cost": "0",
                        "total_cost": "0",
                        "direct_cost": "0"
                    },
                    "fund_type": "competitive_research_funding"
                }
            ]
        }
    ]
}